The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients
European Journal of Cancer2016Vol. 61, pp. 69–76
Citations Over TimeTop 10% of 2016 papers
Ludovic Nguyen-Them, Myrto Costopoulos, Marie‐Laure Tanguy, Caroline Houillier, Sylvain Choquet, Hind Benanni, Rwaida Elias-Shamieh, Marine Armand, Géraldine Faivre, Sylvie Glaisner, Sandra Malak, Jacques Vargaftig, Khê Hoang‐Xuan, Guido Ahle, Valérie Touitou, Nathalie Cassoux, Frédéric Davi, Hélène Merle‐Béral, Magali Le Garff‐Tavernier, Carole Soussain
Related Papers
- → “Compensated hyperosmolarity” of cerebrospinal fluid and the development of hydrocephalus(2013)52 cited
- → Evaluation of a surrogate marker: validity and efficiency(2012)6 cited
- → Surrogate Endpoints in Clinical Trials(1996)29 cited
- → Lipoprotein(a) in the Cerebrospinal Fluid of Neurological Patients with Blood–Cerebrospinal Fluid Barrier Dysfunction(2006)13 cited
- → Cerebrospinal Fluid Thyroxine(1969)9 cited